drugset / Trial / NCT01686568
Omega-3 Fatty Acids and Insulin Sensitivity
Phase 3
Completed
31 enrolled
Mayo Clinic
Building Interdisciplinary Research Careers in Women's Health · collabNational Center for Advancing Translational Sciences (NCATS) · collabNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is being done to understand the effects of dietary omega-3 fats on insulin sensitivity in adult men and women.
Timeline
- Start
- 2012-12-21
- Primary completion
- 2014-10-30
- Completion
- 2015-06-08
Publications
- Results Lalia AZ, Johnson ML, Jensen MD, Hames KC, Port JD, Lanza IR. Effects of Dietary n-3 Fatty Acids on Hepatic and Peripheral Insulin Sensitivity in Insulin-Resistant Humans. Diabetes Care. 2015 Jul;38(7):1228-37. doi: 10.2337/dc14-3101. Epub 2015 Apr 7.
- Hames KC, Morgan-Bathke M, Harteneck DA, Zhou L, Port JD, Lanza IR, Jensen MD. Very-long-chain omega-3 fatty acid supplements and adipose tissue functions: a randomized controlled trial. Am J Clin Nutr. 2017 Jun;105(6):1552-1558. doi: 10.3945/ajcn.116.148114. Epub 2017 Apr 19.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omega-3 fatty acids | Unknown | 3.9 g | Oral |
Indications
No indication recorded.